Platelet-rich Plasma, Corticosteroid, or Lidocaine for Acromioclavicular Joint Pain

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study will compare three different treatment injections for the management of acromioclavicular joint dysfunction (ACJ Dysfunction). Patients that consent and enroll will be randomized to receive (1) a corticosteroid injection, (2) an injection of Platelet Rich Plasma, or (3) a Lidocaine injection. Follow-up will occur over a 1 year period.
Epistemonikos ID: 93f56ab46e3b5a55b43cb68a8b75224e9cf25a40
First added on: May 09, 2024